Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SALBUTAMOL HFA SANIS HEALTH INC Anticipated shortage 100MCG Updated Report 2025-02-10 250070
JAMP IPRATROPIUM HFA JAMP PHARMA CORPORATION Anticipated shortage 20MCG New Report 2025-02-10 250065
TARO-TOFACITINIB TARO PHARMACEUTICALS INC Actual shortage 5MG Updated Report 2025-02-10 250059
TARO-SITAGLIPTIN FUMARATE TARO PHARMACEUTICALS INC Resolved 100MG Updated Report 2025-02-10 237260
TARO-TESTOSTERONE CYPIONATE INJECTION TARO PHARMACEUTICALS INC Actual shortage 100MG Updated Report 2025-02-10 242561
TARO-LURASIDONE TARO PHARMACEUTICALS INC Actual shortage 80MG Updated Report 2025-02-10 248951
TARO-LENALIDOMIDE TARO PHARMACEUTICALS INC Actual shortage 10MG New Report 2025-02-10 250050
TARO-CLOBETASOL SPRAY TARO PHARMACEUTICALS INC Actual shortage 0.05% Updated Report 2025-02-10 248933
TARO-CAPECITABINE TARO PHARMACEUTICALS INC Actual shortage 150MG Updated Report 2025-02-10 249014
TARO-BOSENTAN TARO PHARMACEUTICALS INC Actual shortage 125MG Updated Report 2025-02-10 242501

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
TROSEC SUNOVION PHARMACEUTICALS CANADA INC To be discontinued 20MG Updated Report 2025-02-10 250062
KIVEXA VIIV HEALTHCARE ULC To be discontinued 300MG 600MG Updated Report 2025-02-07 238375
CASODEX ASTRAZENECA CANADA INC Discontinued 50MG Updated Report 2025-02-07 231878
SKYRIZI ABBVIE CORPORATION Discontinued 75MG Updated Report 2025-02-06 248607
NUTROPIN AQ NUSPIN 5 HOFFMANN-LA ROCHE LIMITED Discontinued 5MG Updated Report 2025-02-01 232071